YOU ARE HERE >
MONEYCONTROL >
MARKETS >
Pharmaceuticals
> Quarterly Results - GlaxoSmithKline Pharmaceuticals
GlaxoSmithKline Pharmaceuticals
BSE: 500660|NSE: GLAXO|ISIN: INE159A01016|SECTOR: Pharmaceuticals
LIVE
BSE
May 29, 17:00
1991.80
-11.5 (-0.57%)VOLUME 264
LIVE
NSE
May 29, 17:00
1988.05
-16.75 (-0.84%) VOLUME 1,945
Quarterly Results of GlaxoSmithKline Pharmaceuticals |
------------------- in Rs. Cr. ------------------- |
 | ||||||||||
|
||||||||||
| Mar '12 | Dec '11 | Sep '11 | Jun '11 | Mar '11 | ||||||
|
||||||||||
| Sales Turnover | 629.85 | 576.37 | 613.80 | 572.37 | 609.02 | |||||
| Other Income | 73.34 | -- | -- | -- | 18.00 | |||||
| Total Income | 703.19 | 576.37 | 613.80 | 572.37 | 627.02 | |||||
| Total Expenses | 427.05 | 394.18 | 430.76 | 373.07 | 391.17 | |||||
| Operating Profit | 202.80 | 182.19 | 183.04 | 199.30 | 217.85 | |||||
| Profit On Sale Of Assets | -- | -- | -- | -- | -- | |||||
| Profit On Sale Of Investments | -- | -- | -- | -- | -- | |||||
| Gain/Loss On Foreign Exchange | -- | -- | -- | -- | -- | |||||
| VRS Adjustment | -- | -- | -- | -- | -- | |||||
| Other Extraordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Total Extraordinary Income/Expenses | -92.97 | -10.64 | -0.13 | -4.12 | -185.87 | |||||
| Tax On Extraordinary Items | -- | -- | -- | -- | -- | |||||
| Net Extra Ordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Gross Profit | 276.14 | 182.19 | 183.04 | 199.30 | 235.85 | |||||
| Interest | -- | -41.65 | -37.06 | -29.81 | -33.10 | |||||
| PBDT | 183.17 | 213.20 | 219.97 | 224.99 | 83.08 | |||||
| Depreciation | 4.12 | 6.15 | 4.90 | 4.93 | 4.43 | |||||
| Depreciation On Revaluation Of Assets | -- | -- | -- | -- | -- | |||||
| PBT | 179.05 | 207.05 | 215.07 | 220.06 | 78.65 | |||||
| Tax | 56.16 | 70.31 | 69.21 | 72.52 | 78.19 | |||||
| Net Profit | 122.89 | 136.74 | 145.86 | 147.54 | 0.46 | |||||
| Prior Years Income/Expenses | -- | -- | -- | -- | -- | |||||
| Depreciation for Previous Years Written Back/ Provided | -- | -- | -- | -- | -- | |||||
| Dividend | -- | -- | -- | -- | -- | |||||
| Dividend Tax | -- | -- | -- | -- | -- | |||||
| Dividend (%) | -- | -- | -- | -- | -- | |||||
| Earnings Per Share | 14.51 | 16.14 | 17.22 | 17.42 | 0.05 | |||||
| Book Value | -- | -- | -- | -- | -- | |||||
| Equity | 84.70 | 84.70 | 84.70 | 84.70 | 84.70 | |||||
| Reserves | -- | -- | -- | -- | -- | |||||
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | |||||
| ||||||||||
| Source : Dion Global Solutions Limited | ||||||||||
| ||||||||||
Results of GlaxoSmithKline
- News
- Results
- Estimates
- Analysis
Results of Pharmaceuticals Sector
- News
- Results
- Estimates
- Analysis
Quick Links for glaxosmithklinepharmaceuticals
Related Searches
glaxosmithklinepharmaceuticals Stock Price, GlaxoSmithKline Stock Quote, GlaxoSmithKline Results , GlaxoSmithKline News ..
More »
Follow moneycontrol.com
Explore Moneycontrol
Mutual Funds
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
News |
Markets |
IPO |
Technicals |
Mutual Fund |
Commodities |
Best Portfolio Manager |
Bse Sensex |
Bombay Stock Exchange |
Share Market Live |
Recession 2011 |
Commodities Price |
Silver Price/Rate in India |
Gold Price/Rate in India |
Crude Oil |
USD to INR |
National Stock Exchange |
Bank Fixed Deposits |
Company Fixed Deposits |
Small Savings Schemes |
Property rates in India |
Rss Feeds | Budget:2008, 2009, 2010, 2011, 2012 |
Intuit Money Manager |
RBI Credit Policy | BSE A Group Companies | BSE B Group Stocks | Union Budget
| Financial Glossary
|
Message Board |
Moneybhai |
Connect.in.com |
Business Yellow Pages |
India's Premiere Technology Guide |
History India | Davos
| Kingfisher Airlines | Infosys | BSE Sensex | Air India | Mobile payment | Tata Motors | Sun Pharma | FDI | Siemens | Gasoline
Site Map | About Us | Contact Us | Advertise | Bookmark | Disclaimer | Privacy Statement | Terms of Use | Careers
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.